KHI Board of Directors and Federal Liaisons
Chair
- Jerome A. Rossert, MD, PhD (2029)
FDA Point of Contact
- Kristen Miller, PharmD (2026)
Members
- Shuchi Anand, MD, MS (2027)
- Mary Baliker (2026)
- Steven K. Burke, MD (2027)
- Robin Cooper, MS, RN (2026)
- Bruce F. Culleton, MD (2026)
- Manisha Dadhania, MBA (2026)
- Ogo I. Egbuna, MD, MS, MSc, FASN (2027)
- Jay Elliott, PhD (2026)
- Vanessa A. Evans, MA (2026)
- Amanda Grandinetti, MPH (2026)
- Anthony Gucciardo, RPh (2029)
- Lauren L. Lee, MA (2027)
- John Mcdermott, MBA (2026)
- Jennifer McKenzie, MD (2029)
- Vandana Dua Niyyar, MD, FASN (2026)
- Priti R. Patel, MD, MPH (2029)
- Robert M. Perkins, MD, MPH (2027)
- Ali Poyan Mehr (2029)
- Glenda V. Roberts (2026)
- Bruce M. Robinson, MD, MS, FASN (2026)
- Alain Romero, PharmD, PhD (2026)
- Martin Schreiber, MD (2029)
- Bhupinder Singh, MD, FASN (2029)
- Michael Spigler (2026)
- Howard Trachtman, MD, FASN (2026)
FDA Liaisons
- Kellie Kelm, PhD (2026)
- Aliza M. Thompson, MD, MS (2026)
Ex-Officio
- Curtis Warfield, MS (2026)
Disclosures as of September 2021 can be found here.